Form D · Other Health Care
Dash Bio, Inc.
Boston, MA · CIK 0002041370
Offering snapshot reported Jul 14, 2026 · SEC filing
- Reported sold
- $30M Offering amount: $30M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 15, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 14, 2026 | Initial | $30,000,022 | No comparison | 9 | SEC filing |
| Jun 26, 2025 | Initial | $10,999,976 | No comparison | 12 | SEC filing |
| Oct 17, 2024 | Initial | $6,121,000 | No comparison | 15 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-590658
Source: Form D, filed Jul 14, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Johnson | Director, Executive |
| Andy Smith | Director |
| Alexander Tallett | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
56 Broad Street Ste 14011
Boston, MA, 02109
Boston, MA, 02109